In a new study published in the American Journal of Psychiatry, Dr. Helen Mayberg and colleagues analyzed data from 131 patients with treatment-resistant depression who received subcallosal cingulate deep brain stimulation (DBS), a highly specialized approach in which electrodes are implanted in the brain to deliver electrical stimulation.
The researchers found that sustained improvement was associated with stimulation reaching specific connected white-matter pathways. The findings suggest that successful DBS depends not only on where stimulation is delivered, but on which connected brain pathways are reached.
Why it matters: The study adds to evidence that depression involves networks of connected brain regions and shows how a more individualized understanding of brain connectivity could help researchers refine DBS for people with severe, treatment-resistant depression.
Important context: DBS is a highly specialized, investigational approach for severe treatment-resistant depression. This study helps explain which brain pathways appear important to sustained improvement.
Helen S. Mayberg, M.D., Icahn School of Medicine at Mount Sinai, is a member of HDRF’s Depression Task Force.
Source: Connectomic Determinants of Subcallosal Cingulate Deep Brain Stimulation for Depression, American Journal of Psychiatry.